Cite
HARVARD Citation
Chambers, J. et al. (2019). A Multicentre Study of Pathological Complete Response in HER2-positive Early Breast Cancer Treated with Neoadjuvant Pertuzumab and Trastuzumab. Clinical oncology. 31 (7), pp. e106-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chambers, J. et al. (2019). A Multicentre Study of Pathological Complete Response in HER2-positive Early Breast Cancer Treated with Neoadjuvant Pertuzumab and Trastuzumab. Clinical oncology. 31 (7), pp. e106-. [Online].